Multiply recurrent retroperitoneal liposarcoma
SP Bagaria, E Gabriel, GN Mann - Journal of surgical oncology, 2018 - Wiley Online Library
Retroperitoneal liposarcomas (RPLPS) are rare tumors that represent at least 50% of all
retroperitoneal sarcomas. Surgical resection remains the standard of care. Unfortunately …
retroperitoneal sarcomas. Surgical resection remains the standard of care. Unfortunately …
[HTML][HTML] Resection outcomes for primary and local recurrent retroperitoneal liposarcoma patients
Y Yan, S Xia, D Teng, S Hu, S Li, Y Wang… - Annals of Translational …, 2020 - ncbi.nlm.nih.gov
Background The clinical characteristics of primary retroperitoneal liposarcoma (PR RPLPS)
and local recurrent retroperitoneal liposarcoma (LR RPLPS) cases were compared to …
and local recurrent retroperitoneal liposarcoma (LR RPLPS) cases were compared to …
Retroperitoneal liposarcomas: the experience of a tertiary Asian center
Background Liposarcoma is the single most common soft tissue sarcoma in the
retroperitoneum. Materials and methods A retrospective review of patients with primary …
retroperitoneum. Materials and methods A retrospective review of patients with primary …
Recurrent retroperitoneal liposarcoma: A case report and literature review
Recurrent retroperitoneal liposarcoma: A case report and literature review - Mulita - 2021 -
Clinical Case Reports - Wiley Online Library Skip to Article Content Skip to Article Information …
Clinical Case Reports - Wiley Online Library Skip to Article Content Skip to Article Information …
Analysis of differentiation changes and outcomes at time of first recurrence of retroperitoneal liposarcoma by transatlantic australasian retroperitoneal sarcoma …
C Nessim, CP Raut, D Callegaro, F Barretta… - Annals of surgical …, 2021 - Springer
Background Local recurrence following resection of retroperitoneal liposarcoma (RLPS) is
common. Well-differentiated (WD) and dedifferentiated (DD) RLPS are distinct entities with …
common. Well-differentiated (WD) and dedifferentiated (DD) RLPS are distinct entities with …
Characteristics of primary and repeated recurrent retroperitoneal liposarcoma: outcomes after aggressive surgeries at a single institution
K Ishii, Y Yokoyama, Y Nishida, H Koike… - Japanese Journal of …, 2020 - academic.oup.com
Objective This study sought to investigate the characteristics of primary and repeated
recurrent retroperitoneal liposarcoma. Methods Patients treated with primary or recurrent …
recurrent retroperitoneal liposarcoma. Methods Patients treated with primary or recurrent …
Surgical management of primary and recurrent retroperitoneal liposarcoma
SJ Neuhaus, P Barry, MA Clark, AJ Hayes… - Journal of British …, 2005 - academic.oup.com
Background Surgery plays a dominant role in the initial and subsequent treatment of
retroperitoneal liposarcoma (RPLS). This study was a review of outcomes of patients treated …
retroperitoneal liposarcoma (RPLS). This study was a review of outcomes of patients treated …
[HTML][HTML] Clinical features of multiply recurrent retroperitoneal liposarcoma: A single-center experience
Background To elucidate the clinicopathological features of multiply recurrent
retroperitoneal liposarcoma referred to a tertiary center. Methods We retrospectively …
retroperitoneal liposarcoma referred to a tertiary center. Methods We retrospectively …
Management of retroperitoneal liposarcoma: A case report and review of the literature
WD Zhang, DR Liu, RS Que, CB Zhou… - Oncology …, 2015 - spandidos-publications.com
Retroperitoneal liposarcoma is a rare tumor with an incidence of 2.5 per million individuals.
Early diagnosis is difficult as there is an absence of specific clinical presentations. The …
Early diagnosis is difficult as there is an absence of specific clinical presentations. The …
Management of high-grade retroperitoneal liposarcomas: personal experience
Sarcomas are uncommon malignant tumors arising from mesenchymal tissue, accounting
for approximately 10% of soft-tissue sarcomas and less than 1% of all malignant neoplasms …
for approximately 10% of soft-tissue sarcomas and less than 1% of all malignant neoplasms …